Ilyas SI - Search Results

1

Pathogenesis, diagnosis, and management of cholangiocarcinoma.

Ilyas SI, Gores GJ. Ilyas SI, et al. Gastroenterology. 2013 Dec;145(6):1215-29. doi: 10.1053/j.gastro.2013.10.013. Epub 2013 Oct 15. Gastroenterology. 2013. PMID: 24140396 Free PMC article. Review.

2

Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma.

Fingas CD, Mertens JC, Razumilava N, Sydor S, Bronk SF, Christensen JD, Ilyas SI, Canbay A, Treckmann JW, Paul A, Sirica AE, Gores GJ. Fingas CD, et al. Among authors: ilyas si. Hepatology. 2013 Oct;58(4):1362-74. doi: 10.1002/hep.26484. Epub 2013 Aug 6. Hepatology. 2013. PMID: 23703673 Free PMC article.

3

Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis.

Ilyas SI, Mertens JC, Bronk SF, Hirsova P, Dai H, Roberts LR, Kaufmann SH, Gores GJ. Ilyas SI, et al. J Biol Chem. 2014 Aug 15;289(33):22835-22849. doi: 10.1074/jbc.M114.563064. Epub 2014 Jun 27. J Biol Chem. 2014. PMID: 24973208 Free PMC article.

4

IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism.

Yamada D, Ilyas SI, Razumilava N, Bronk SF, Davila JI, Champion MD, Borad MJ, Bezerra JA, Chen X, Gores GJ. Yamada D, et al. Among authors: ilyas si. Hepatology. 2015 May;61(5):1627-42. doi: 10.1002/hep.27687. Epub 2015 Mar 20. Hepatology. 2015. PMID: 25580681 Free PMC article.

5

Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management.

Ilyas SI, Eaton JE, Gores GJ. Ilyas SI, et al. Clin Gastroenterol Hepatol. 2015 Nov;13(12):2152-65. doi: 10.1016/j.cgh.2015.05.035. Epub 2015 Jun 5. Clin Gastroenterol Hepatol. 2015. PMID: 26051390 Free PMC article. Review.

6

Liver capsule: Cholangiocarcinoma (CCA).

Ilyas SI, Gores GJ. Ilyas SI, et al. Hepatology. 2016 Apr;63(4):1356. doi: 10.1002/hep.28401. Epub 2016 Feb 1. Hepatology. 2016. PMID: 26667406 Free PMC article. No abstract available.

7

A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma.

Ilyas SI, Yamada D, Hirsova P, Bronk SF, Werneburg NW, Krishnan A, Salim W, Zhang L, Trushina E, Truty MJ, Gores GJ. Ilyas SI, et al. J Biol Chem. 2016 Apr 8;291(15):8031-47. doi: 10.1074/jbc.M115.698472. Epub 2016 Jan 29. J Biol Chem. 2016. PMID: 26826125 Free PMC article.

8

Emerging molecular therapeutic targets for cholangiocarcinoma.

Ilyas SI, Gores GJ. Ilyas SI, et al. J Hepatol. 2017 Sep;67(3):632-644. doi: 10.1016/j.jhep.2017.03.026. Epub 2017 Apr 5. J Hepatol. 2017. PMID: 28389139 Free PMC article. Review.

9

Targeting cholangiocarcinoma.

Mertens JC, Ilyas SI, Gores GJ. Mertens JC, et al. Among authors: ilyas si. Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1454-1460. doi: 10.1016/j.bbadis.2017.08.027. Epub 2017 Aug 24. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 28844952 Free PMC article. Review.

10

Cholangiocarcinoma - evolving concepts and therapeutic strategies.

Ilyas SI, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Ilyas SI, et al. Nat Rev Clin Oncol. 2018 Feb;15(2):95-111. doi: 10.1038/nrclinonc.2017.157. Epub 2017 Oct 10. Nat Rev Clin Oncol. 2018. PMID: 28994423 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters